SEATTLE--(BUSINESS WIRE)--Dendreon Corporation (Nasdaq: DNDN) today announced that John H. Johnson has been elected to the Company’s Board of Directors, effective August 18, 2011. Mr. Johnson is currently the chief executive officer of Savient Pharmaceuticals, Inc. (Nasdaq: SVNT), where he has also served as a member of its Board of Directors since January 2011.
